CBM - Cambrex Corporation

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
575,256
532,093
534,456
490,644
433,326
Cost of Revenue
376,504
335,405
304,369
286,419
256,361
Gross Profit
198,752
196,688
230,087
204,225
176,965
Operating Expenses
Research Development
14,935
15,547
16,901
14,292
12,540
Selling General and Administrative
86,719
68,506
70,468
60,422
57,867
Total Operating Expenses
101,654
84,053
87,369
74,714
70,407
Operating Income or Loss
97,098
112,635
142,718
129,511
106,558
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-14,072
1,137
360
-1,255
-15,294
Income Before Tax
67,788
109,805
141,825
127,539
89,565
Income Tax Expense
13,466
16,596
38,061
40,214
32,389
Income from Continuing Operations
54,322
93,209
103,764
87,325
57,176
Net Income
53,968
92,418
102,450
81,678
57,217
Net Income available to common shareholders
53,968
92,418
102,450
81,678
57,217
Reported EPS
Basic
-
2.78
3.14
2.55
1.82
Diluted
-
2.75
3.06
2.48
1.76
Weighted average shares outstanding
Basic
-
33,243
32,662
32,086
31,420
Diluted
-
33,665
33,486
32,969
32,555
EBITDA
-
112,635
142,718
154,176
106,558